Pheochromocytoma
📧 Sign up to get email alerts when something new happens for Pheochromocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: The Efficacy and Safety of Temozolomide in Patients With MPPGL [Phase 2]
Phase 2 trial evaluating temozolomide for malignant pheochromocytoma and paraganglioma has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma [Phase 2]
A Phase 2 randomized international trial in malignant progressive pheochromocytoma and paraganglioma has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial [Phase 2]
Phase II open-label single-arm study evaluating efficacy and safety of anlotinib in advanced or metastatic pheochromocytoma/paraganglioma.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma [Phase 2]
Phase 2 trial evaluating dexmedetomidine and magnesium sulfate in open resection of pheochromocytoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating lenvatinib for metastatic or advanced pheochromocytoma or paraganglioma that cannot be surgically removed;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer [Phase 2]
A Phase II trial of the DNA methyltransferase inhibitor guadecitabine (SGI-110) in children and adults with wild-type GIST, paraganglioma, p…
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma [Phase 2]
Phase II study evaluating axitinib (AG-013736) targeting VEGF pathway in metastatic/recurrent/unresectable pheochromocytoma and paragangliom…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Dovitinib in Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib in neuroendocrine tumors (paraganglioma and pheochromocytoma) completed.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma [Phase 3]
A Phase 3 clinical trial evaluating meta-iodobenzylguanidine (123I mIBG) scintigraphy in patients being evaluated for pheochromocytoma or ne…
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma [Phase 2]
Phase 2 study evaluating ultratrace Iobenguane I-131 in malignant relapsed/refractory pheochromocytoma and paraganglioma; results posted in …
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors [Phase 2]
Phase II clinical trial evaluating 131I-Metaiodobenzylguanidine (MIBG) for metastatic or unresectable pheochromocytoma and related tumors ha…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: 131MIBG to Treat Malignant Pheochromocytoma [Phase 2]
A Phase 2 clinical trial investigating iobenguane I-131 (131I-MIBG) for malignant pheochromocytoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study [NA]
This completed trial evaluated the efficacy and safety of posterior retroperitoneoscopic adrenalectomy in adrenal diseases, including pheoch…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma [Phase 2]
Phase 2 trial of pazopanib hydrochloride in advanced or progressive malignant pheochromocytoma or paraganglioma was terminated with results …
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety and feasibility of radiolabeled octreotide in pediatric patients with advanced or refractory s…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]
Phase 1/2 study of iobenguane I-131 (MIBG) in patients with malignant pheochromocytoma or paraganglioma completed; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers [NA]
This completed clinical trial evaluated screening methods to detect tumors in SDH-positive carriers, addressing hereditary paraganglioma and…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid [Phase 2]
A Phase 2 trial of RAD001 (everolimus) for pheochromocytoma, extra-adrenal paraganglioma, and non-functioning carcinoid has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot [NA]
A completed pilot study assessing the feasibility of Iodine-123 IBZM scintigraphy as a diagnostic imaging tool in patients with pheochromocy…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma
This clinical trial evaluated non-invasive methods for assessing fluid status and cardiac output during the operative treatment of pheochrom…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy [Phase 4]
A Phase 4 randomized trial comparing posterior retroperitoneoscopic adrenalectomy with lateral laparoscopic adrenalectomy for adrenal tumors…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and tamoxifen in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating internal radiation therapy for liver metastases from neuroendocrine tumors was terminated.